Рандомизированное, двойное слепое исследование III фазы с целью сравнения препарата ABT-494 с плацебо и с адалимумабом у пациентов со среднетяжелым или тяжелым активным течением ревматоидного артрита, получаюших стабильную фоновую терапию метотрексатом и не достигших адекватного ответа не нее
Клинические исследования и проекты
идёт · новые препараты · найдено 995
A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Are on a Stable Background of Methotrexate (MTX) and Who Have an Inadequate Response to MTX (MTX-IR)
№ Неоадъювантная химиотерапия наб-паклитакселом женщин с раком молочной железы с негативным рецептором человеческого эпидермального фактора роста 2, находящихся в группе высокого риска рецидива заболевания
Рандомизированное двойное слепое плацебо-контролируемое многоцентровое исследование III фазы по поддерживающей монотерапии олапарибом у пациентов с распространенным раком яичников (стадия FIGO III-IV) с мутацией BRCA после первой линии химиотерапии, содержащей препараты платины
PRIDE III Prison Interventions and HIV Prevention Collaboration
CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan
Integrating Evidence-based Approaches to Prevent Child Maltreatment in Kyrgyzstan
Study of the Effectiveness and Safety of Embolization of the Middle Meningeal Artery Using Non-adhesive Materials SQUID 12 and SQUID 18 in the Treatment of Patients With Chronic Resistant Migraine
Expanding Medication-Assisted Therapies in Central Asia
Prospective Urban Rural Epidemiology Study
An Open-Label, Multicenter, Extension Study for Subjects Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
A Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of TX000045 After 24 Weeks of Treatment in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (PH-HFpEF)
Implementing a Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries: a Process and Outcome Evaluation
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
Global Registries And Surveys Programme - Heart Failure Snapshot Study (GRASP-HF)
European ColoSeal™ ICD System Safety and Feasibility Study
Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)
An International Multicenter Open-label Clinical Study of the Safety and Efficacy of RPH-104 for Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
An Open-Label Early Access Phase 3b Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma
Improving Cancer Outcomes for Children, Adolescents, and Young Adults: A Multicenter Prospective Cohort Study on Treatment Failure and Toxicity in Low- and Middle-Income Countries.